Nobuko Ishii
Overview
Explore the profile of Nobuko Ishii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirano K, Ichikawa T, Nakao K, Matsumoto A, Miyaaki H, Shibata H, et al.
Liver Transpl
. 2008 Feb;
14(3):292-8.
PMID: 18306331
The premise of our study is that selective inhibition of interferon (IFN) by calcineurin inhibitors contribute to the increased severity of hepatitis C virus (HCV) posttransplantation. Therefore, we examined the...
2.
Morimoto K, Morikawa M, Kimura H, Ishii N, Takamata A, Hara Y, et al.
Life Sci
. 2007 Dec;
82(1-2):99-107.
PMID: 18061622
Mental stress is thought to underlie cardiovascular events, but there is information on oxidative stress induced by mental stress in association with cardiovascular responses in women. Using a sensitive assay...
3.
Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N
Oncol Rep
. 2006 Jul;
16(2):389-92.
PMID: 16820920
Survivin, an anti-apoptotic protein, is abundantly expressed in a variety of cancer cells, including hepatoma cells, resulting in the resistance of these cells to various apoptotic stimuli. Tumor necrosis factor...
4.
Motoyoshi Y, Kaminoda K, Saitoh O, Hamasaki K, Nakao K, Ishii N, et al.
Oncol Rep
. 2006 Jun;
16(1):141-6.
PMID: 16786137
It is known that, besides its direct cytotoxic effect as an alkylating chemotherapeutic agent, cyclophosphamide also has immuno-modulatory effects, such as depletion of CD4+CD25+ regulatory T cells. However, its optimal...
5.
Hayashi T, Nakao K, Nagayama Y, Saitoh O, Ichikawa T, Ishikawa H, et al.
Int J Oncol
. 2005 Apr;
26(5):1313-9.
PMID: 15809723
Dendritic cell (DC)-based vaccine is a developing strategy to treat cancer including hepatoma. We evaluated the antitumor efficacy of vaccination with DCs pulsed with apoptotic cells, as compared to vaccination...
6.
Ishida Y, Migita K, Izumi Y, Nakao K, Ida H, Kawakami A, et al.
FEBS Lett
. 2004 Jul;
569(1-3):156-60.
PMID: 15225625
In this study, we examined whether interleukin-18 (IL-18) affects natural killer (NK) cells' migration and matrix metalloproteinases (MMPs) production. We demonstrated that chemotaxis of human NK cells through basement membrane-like...
7.
Tanaka K, Towata S, Nakao K, Mizuguchi H, Hayakawa T, Niwa M, et al.
Clin Endocrinol (Oxf)
. 2004 Feb;
59(6):734-42.
PMID: 14974915
Background: Introduction of genes encoding immuno-stimulatory cytokine(s) into cancer cells is well known to enhance anti-tumour immunity. Aim: The present studies were designed to evaluate the therapeutic efficacy of retroviral-...
8.
Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T, et al.
Int J Mol Med
. 2003 Dec;
13(1):111-6.
PMID: 14654980
Antitumor vaccination therapy approaches using naked plasmid DNA or recombinant viruses encoding tumor-associated antigens are currently in development. In the present study, we examined the therapeutic efficacy of vaccination using...
9.
Nakao K, Hamasaki K, Wakihama N, Maeda M, Ohtsubo N, Sagiike T, et al.
Vaccine
. 2003 Aug;
21(25-26):3789-94.
PMID: 12922112
In this study, we analyzed anti-HBs levels in 104 Japanese healthcare workers who received three booster HBV surface antigen (HBsAg) vaccines because 80 became anti-HBs-negative at a mean of 2.4...
10.
Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, et al.
Oncogene
. 2003 Mar;
22(11):1653-62.
PMID: 12642868
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, induces apoptosis in a variety of cancer cells with little or no effect on normal cells. Human...